Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction
New England Journal of Medicine · 05.02.2026 · 394 (6) · 540-550
DOI: 10.1056/nejmoa2512686 ↗Kurz gefasst
Metaanalyse in der Zeitschrift New England Journal of Medicine, erschienen am 05.02.2026. Verfasst von Anna Meta Dyrvig Kristensen und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Heart Failure, Myocardial Infarction, Stroke Volume. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Swedish Research Council, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Hjerteforeningen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen.
- Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid.
- Department of Cardiology, University Hospital Son Espases, Instituto de Investigación Sanitaria Islas Baleares, Palma de Mallorca, Spain.
- Facultad de Medicina, Universitat de les Illes Balears, Palma de Mallorca, Spain.
- Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares, Madrid.
- Department of Cardiology, Oslo University Hospital, Ullevål, Oslo.
ORCID-Profile: Michael Maeng
Förderung
- Swedish Research Council
- Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Hjerteforeningen
- South-Eastern Norway Regional Health Authority, the Research Council of Norway
- Research Institute for Production Development
- Novo Nordisk Fonden
Zitieren
APA
Kristensen, A. M. D., Rossello, X., Atar, D., Yndigegn, T., Kimura, T., Latini, R., Lindahl, B., Halvorsen, S., Olsen, M. H., Fuster, V., Hofmann, R., Vikenes, K., Maeng, M., Erlinge, D., Pocock, S., Karlström, P., Bakken, A., Lange, T., Barrabés, J. A., …, & Beta-Blocker Trialists’ Collaboration Study Group (2026). Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction. New England Journal of Medicine, 394(6), 540-550. https://doi.org/10.1056/nejmoa2512686
Vancouver
Kristensen AMD, Rossello X, Atar D, Yndigegn T, Kimura T, Latini R, et al. Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction. New England Journal of Medicine. 2026;394(6):540-550. doi:10.1056/nejmoa2512686
BibTeX
@article{Kristensen2026,
author = {Kristensen, Anna Meta Dyrvig and Rossello, Xavier and Atar, Dan and Yndigegn, Troels and Kimura, Takeshi and Latini, Roberto and Lindahl, Bertil and Halvorsen, Sigrun and Olsen, Michael Hecht and Fuster, Valentin and Hofmann, Robin and Vikenes, Kjell and Maeng, Michael and Erlinge, David and Pocock, Stuart and Karlström, Patric and Bakken, Arnhild and Lange, Theis and Barrabés, Jose A and Benatar, Jocelyne and Raposeiras-Roubin, Sergio and Held, Claes and Piepoli, Massimo and Fagerland, Morten Wang and Holmager, Therese and Ozasa, Neiko and Prescott, Eva Irene Bossano and Munkhaugen, John and Jernberg, Tomas and Ibanez, Borja and Beta-Blocker Trialists’ Collaboration Study Group, Beta-Blocker Trialists’ Collaboration Study Group},
title = {Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {6},
pages = {540--550},
doi = {10.1056/nejmoa2512686}
}
EUVIMED